Core Laboratories Inc.
US ˙ NYSE ˙ US21867A1051

Introduction

This page provides a comprehensive analysis of the known insider trading history of Jan Willem Sodderland. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Jan Willem Sodderland has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CLB / Core Laboratories Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Jan Willem Sodderland. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CLB / Core Laboratories Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLB / Core Laboratories Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2020-05-07 CLB Sodderland Jan Willem 600 17.0700 600 17.0700 10,242 307 41.3200 14,550 142.06
2018-10-29 CLB Sodderland Jan Willem 200 85.7600 200 85.7600 17,152
2016-02-02 CLB Sodderland Jan Willem 300 93.9000 300 93.9000 28,170
2015-07-24 CLB Sodderland Jan Willem 300 106.2000 300 106.2000 31,860
2015-02-02 CLB Sodderland Jan Willem 300 94.5400 300 94.5400 28,362
2014-07-30 CLB Sodderland Jan Willem 200 147.8850 200 147.8850 29,577
2014-02-28 CLB Sodderland Jan Willem 100 188.6400 100 188.6400 18,864

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLB / Core Laboratories Inc. Insider Trades
Insider Sales CLB / Core Laboratories Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLB / Core Laboratories Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLB / Core Laboratories Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Jan Willem Sodderland as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2020-05-11 2020-04-01 4/A CLB CORE LABORATORIES N V
Restricted Shares 		J - Other -14,507 0 -100.00
2020-05-07 2020-05-07 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 600 7,852 8.27 17.07 10,242 134,034
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 14,507 14,507
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -2,177 0 -100.00
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -1,078 7,252 -12.94 9.49 -10,230 68,821
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 2,177 8,330 35.38
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 2,177 2,177
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,387 0 -100.00
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,335 0 -100.00
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -722 6,153 -10.50 68.93 -49,767 424,126
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,387 6,875 25.27
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -695 5,488 -11.24 68.93 -47,906 378,288
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,335 6,183 27.54
2018-10-30 2018-10-29 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 200 4,848 4.30 85.76 17,152 415,764
2018-04-03 2018-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,299 0 -100.00
2018-04-03 2018-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,387 1,387
2018-04-03 2018-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -676 4,648 -12.70
2018-04-03 2018-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,299 5,324 32.27
2018-04-03 2018-03-31 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,436 0 -100.00
2018-04-03 2018-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -747 4,025 -15.65
2018-04-03 2018-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,436 4,772 43.05
2017-04-05 2017-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,299 1,299
2017-04-05 2017-03-31 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -756 0 -100.00
2017-04-05 2017-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -394 3,336 -10.56 115.52 -45,515 385,375
2017-04-05 2017-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 756 3,730 25.42
2016-04-01 2016-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,335 1,335
2016-04-01 2016-03-31 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,088 0 -100.00
2016-04-01 2016-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -566 2,974 -15.99 112.41 -63,624 334,307
2016-04-01 2016-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,088 3,540 44.37
2016-02-03 2016-02-02 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 300 2,452 13.94 93.90 28,170 230,243
2015-07-27 2015-07-24 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 300 2,152 16.20 106.20 31,860 228,542
2015-04-02 2015-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,436 1,436
2015-04-02 2015-03-31 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,141 0 -100.00
2015-04-02 2015-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -594 1,852 -24.28 104.49 -62,067 193,515
2015-04-02 2015-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,141 2,446 87.43
2015-02-02 2015-02-02 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 300 1,305 29.85 94.54 28,362 123,375
2014-07-31 2014-07-30 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 200 1,005 24.84 147.88 29,577 148,624
2014-04-02 2014-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 756 756
2014-04-02 2014-03-31 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -1,469 0 -100.00
2014-04-02 2014-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -764 805 -48.69 198.44 -151,608 159,744
2014-04-02 2014-03-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 1,469 1,569 1,469.00
2014-03-04 2014-02-28 4 CLB CORE LABORATORIES N V
Common Shares 		P - Purchase 100 100 188.64 18,864 18,864
2013-05-01 2013-05-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,088 1,088
2012-04-03 2012-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		A - Award 1,141 1,141
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)